共 50 条
- [24] Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2+ pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG mice JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 8 (07)
- [25] A Phase I Study to Determine the Maximum Tolerated Dose of ex Vivo Expanded Natural Killer Cells Derived from Unrelated, HLA-Disparate Adult Donors TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (05): : 250.e1 - 250.e8
- [28] Phenotypic and functional characterisation of locally produced natural killer cells ex vivo expanded with the K562-41BBL-mbIL21 cell line Clinical and Experimental Medicine, 2023, 23 : 2551 - 2560